2017
DOI: 10.1021/acsbiomaterials.7b00276
|View full text |Cite
|
Sign up to set email alerts
|

In Vitro and In Vivo Characterization of Premixed PMMA-CaP Composite Bone Cements

Abstract: Acrylic bone cements, although successful in the field of orthopedics, suffer from a lack of bioactivity, not truly integrating with surrounding bone. Bioactive fixation is expected to enhance cement performance because of the natural interlocking and bonding with bone, which can improve the augmentative potential of the material in applications such as vertebroplasty (VP). In a recent study, two composite cements (PMMA-hydroxyapatite and PMMA-brushite) showed promising results demonstrating no deterioration i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
14
0
1

Year Published

2018
2018
2021
2021

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 22 publications
(15 citation statements)
references
References 35 publications
0
14
0
1
Order By: Relevance
“…The mechanical testing included monotonic compression and cyclical fatigue tests, in which up to 57% of both PMMA–brushite and PMMA–HA reached sequence 4, demonstrating efficient reinforcement of the fractured vertebrae through stiffness restoration. 161 In their following research, 162 the biological performance of two PMMA–CaP cements were characterized. ALP assays showed no inhibition of osteoblast differentiation on the cement surface.…”
Section: Limitations and Improvements Of Capmentioning
confidence: 99%
“…The mechanical testing included monotonic compression and cyclical fatigue tests, in which up to 57% of both PMMA–brushite and PMMA–HA reached sequence 4, demonstrating efficient reinforcement of the fractured vertebrae through stiffness restoration. 161 In their following research, 162 the biological performance of two PMMA–CaP cements were characterized. ALP assays showed no inhibition of osteoblast differentiation on the cement surface.…”
Section: Limitations and Improvements Of Capmentioning
confidence: 99%
“…A biomaterial is defined as any substance or combination of materials, other than drugs or synthetic natural materials, which can be used, for any period, to partially substitute for any tissue, organ or function of the body for the purpose of maintaining or improving the lifespan of an individual [1]. A fundamental requirement of a biomaterial used in clinical medicine is that it is biocompatible, that is, it can coexist with human tissue without causing any undesirable or inappropriate effects [2,3]. Biomaterials can be classified into three main categories: bioinert, intolerant materials that are not capable of inducing any biological interfacial bond between the implant and the host tissue [4,5]; bioactive, capable of interacting with body tissues, forming chemical or biological bonds and favouring the development of processes such as implant fixation, colonisation and tissue regeneration; and bioreabsorbable, materials that are gradually reabsorbed until they disappear entirely and are wholly replaced by new tissue in vivo.…”
Section: Introductionmentioning
confidence: 99%
“…The other is to thoroughly and evenly mix the drug lyophilized powder or ne particles with bone cement powder component. The drug is added in the dough phase so that the drug is wrapped within the bone cement dough [38,39] . The rst method is used in various antibiotic loaded bone cement on the market, such as Palacos ® R+G, CMW ® 1G etc.…”
Section: Principles Of Pmma Bone Cement As Drug Carriersmentioning
confidence: 99%